Facebook
X
LinkedIn
Forward
Highlights in GI Oncology 2026
Highlights in GI Oncology is a program designed to provide the latest science and education from the world’s premier GI oncology event, the ASCO Gastrointestinal Cancers Symposium. The abstracts selected for presentation and discussion reflect the foremost research and strategies in oncology that will impact clinical practice and patient care.
The program features in-depth discussion and analysis of the latest scientific findings and practice-changing advances in GI cancer treatment. Expert faculty will review the findings, discuss the results potential impact on the current standard of care, and apply the results within the clinical context of a patient case.
Learning Objectives
- Summarize key advances presented at the ASCO GI Cancers Symposium
- Review the latest data for the perioperative and advanced treatment of GI cancers
- Apply the latest clinical data to practice to optimize care and outcomes for patients with GI cancers
- Identify the latest advances for the role of molecular testing in the management of gastrointestinal malignancies
- Discuss current challenges and controversies in the management of GI cancers
Designation | Early Bird Deadline November 20, 2025 | Advanced Deadline January 20, 2026 | General Registration Deadline February 20, 2026 |
| Physicians | $125 | $175 | $225 |
Pharmacists | $75 | $100 | $125 |
NPs, PAs | $75 | $100 | $125 |
| RNs, and others | $60 | $85 | $110 |
Pharma / Med Device Company Employee** | $525 | $575 | $625 |
Students & Fellows* | $Free* | ||
Refunds of 50% of the registration fee will be provided if you cancel up to 30 days before Highlights in GI Oncology 2026 commences. There are no refunds for cancellations within the 30-day window of the start of the event. To request a refund, please email [email protected]
**Defined as anyone employed by a drug, device, or diagnostic company. We allow Industry Professionals to register for our conferences unless you are employed in a sales role with your company. Please note that we will accept a limited number of Industry Professionals (excluding sales) to each conference.
*Student is defined as currently enrolled in an advanced learning institution and/or studying in order to enter a particular profession. If you would like to attend as a Student, please contact [email protected] for further information.
Horizon CME will NOT provide international travelers with an invitation letter to attend this in-person activity. If you reside outside the United States or Canada and register and pay for this event, AND you are unable to obtain a visa to attend, no refund will be issued.
Intended Learners
This CME initiative is designed for oncologists, surgeons, radiation oncologists, NPs, PAs, pharmacists, nurses, and other healthcare professionals involved in the treatment of patients with GI cancers.
Privacy Statement: For online registration, we take precautions to protect your information. When you submit sensitive information via the website, your information is protected both online and offline. In order to use this website, a user must first complete the registration form. During registration, a user is required to give certain information (such as name, email/mailing address and payment information). This information is confidential and will only be used to contact you regarding your registration. Cancellation Policy: Fees are non-refundable and non-transferable.
Presented By
Please note: times are subject to change. Please check the syllabus for the most current version of the agenda upon arriving at the summit.
All Times Listed are for the Eastern Standard Time Zone
| Friday, February 20, 2026 | |
|---|---|
| 1:00pm | Registration Open and Set Up |
| 1:30pm | Gather for Lunch |
| 1:35pm | Buffet Lunch & Non-CME/CE Presentation Sponsored by TBA » TBA |
| 2:20pm | Welcome, Introductions, & CE Housekeeping |
| 2:30pm | (01) Colorectal Cancer: Latest Updates » Tiago Biachi, MD, PhD - Associate Member, Department of Gastrointestinal Oncology | Moffitt Cancer Center | Tampa, FL |
| 3:15pm | Break - Refreshments in Exhibit Hall |
| 3:30m | (02) Colorectal Cancer: Cased Based Discussion » Moderator: Tiago Biachi, MD, PhD - Associate Member, Department of Gastrointestinal Oncology | Moffitt Cancer Center | Tampa, FL » TBA » TBA |
| 4:30pm | (03) Stump the Faculty Q+A » Faculty from Sessions (01) - (02) |
| 4:45pm | Network Reception In Exhibit Hall |
| Saturday, February 21, 2026 | |
| 7:00am | Check-in & Breakfast Available in Exhibit Hall |
| 7:50am | Welcome, Introductions, & CE Housekeeping |
| 8:00am | (04) Keynote Session: RAS ON Inhibitors » TBA |
| 9:00am | Break - Refreshments in the Exhibit Hall |
| 9:15am | (05) Updates in Advances in Metastatic Pancreatic Cancer + Locally Advanced and Neo/Adjuvant Approaches » Philip A. Philip, MD, PhD, FRCP - Director, Gastrointestinal Oncology | Co-Director, Pancreatic Cancer Center | Henry Ford Health | Detroit, MI |
| 9:45am | (06) Pancreas Tumor Board: Case Discussions and Q&A » Moderator: Philip A. Philip, MD, PhD, FRCP - Director, Gastrointestinal Oncology | Co-Director, Pancreatic Cancer Center | Henry Ford Health | Detroit, MI » TBA » TBA » TBA |
| 10:15am | Break - Trivia for Charity in the Exhibit Hall |
| 10:40am | (07) New Advances in Interventional Endoscopy in GI Malignancies » Mustafa Arain, MD - Gastroenterologist | AdventHealth | Orlando, FL |
| 11:10am | (08) Biliary Cancer: Recent Developments » TBA |
| 11:40am | (09) Stump the Faculty Q+A » Faculty for Sessions (05) - (08) |
| 11:55am | Gather for Lunch |
| 12:00pm | Buffet Lunch & Non-CE/CME Symposium Presentation Sponsored by TBA » TBA |
| 12:45pm | Dessert Break in Exhibit Hall |
| 1:00pm | (10) Hepatocellular Carcinoma: Latest Insights » Umair Majeed, MD, MBBS - Hematologist, Oncologist | Mayo Clinic | Jacksonville, FL |
| 1:30pm | (11) Interventional Radiology Developments in Liver Directed Therapies » Mustafa Al-Roubaie, MD - Vascular and Interventional Radiologist | Department of Diagnostic Imaging and Interventional Radiology | Moffitt Cancer Center | Tampa, FL |
| 2:00pm | (12) Updates in Neuroendocrine Cancers » Jonathan Strosberg, MD - Section Head, Neuroendocrine Division, Moffitt Cancer Center | Chair of the Gastrointestinal Department Research, Moffitt Cancer Center | Assistant Professor, University of South Florida, College of Medicine, Department of Oncologic Sciences | Tampa, FL |
| 2:30pm | Break - Refreshments in the Exhibit Hall |
| 2:45pm | (13) Neuroendocrine Cases » Samantha Seitter, DO, MS - Surgical Oncology Fellow | Moffitt Cancer Center | Falls Church, VA » TBA » TBA |
| 3:15pm | (14) Stump the Faculty Q+A » Faculty from Sessions (10) - (13) |
| 3:30pm | Break - Refreshments in the Exhibit Hall |
| 3:15pm | (15) Advances in Metastatic Esophageal and Gastric Cancers » Rutika J. Mehta, MB, BS, MD, MPH - Associate Professor in Medicine, Attending Physician | Weill Cornell Medicine, New York-Presbyterian Hospital | New York, NY |
| 4:15pm | (16) Non-Metastatic Esophageal and Gastric Cancer: GE Junction Patient Cases – Locally Advanced vs. Metastatic » Joseph Kim, MD - Internal Medicine Fellow | Mayo Clinic | Jacksonville, FL » TBA » TBA » TBA |
| 4:45pm | (17) Stump the Faculty Q+A » Faculty from Sessions (15) - (16) |
| 5:00pm | Adjourn |
We want to ensure that your time at the Highlights in GI Oncology 2026 conference is convenient and memorable. Staying at our host hotel provides a hassle-free experience and puts you at the heart of the activity surrounding the conference.
Overnight Accommodations:
Dates for discounted rates: February 18 - 21, 2026
Discounted Booking Deadline: January 19, 2026
Click here to book your room today!
Room rate: $289 plus taxes & fees
Parking:
- Self-parking: $38 per night
- Valet parking: $54 per night
Disclaimer
All reservations must be booked using the link above before the closing date listed. Overnight accommodation, parking, and resort fees will revert back to standard hotel pricing outside of the dates above. A set number of rooms have been blocked off for the discounted pricing. If all of those rooms have already been booked, discounted pricing may not be available for additional rooms or accommodations.
Planning Committee Members
Hani Babiker, MD
Associate Professor of Medicine,
Pancreaticobiliary, GI Oncology, Early Phase Therapeutics, and Consultant
Mayo Clinic
Jacksonville, FL
Dr. Hani Babiker is an Oncologist with board certification in Oncology and Hematology and initial certification in Internal Medicine and Geriatrics and Gerontology. He held academic appointments at the Translational Genomics Research Institute (TGen) and the University of Arizona. Prior to joining the Mayo Clinic, he was the Director of the Early Phase Clinical Trials Program and Co-Chair of DSMB at the University of Arizona Cancer Center. His research interests are in new drug development and in the treatment of gastrointestinal cancers with an emphasis on pancreatic cancer. He completed a drug development scholarship at the Virginia G Piper Cancer Center Clinical Trials/HonorHealth Research Institute in Scottsdale where he served as the principal investigator in many early phase clinical trials in solid tumors and participated in trials that led to drug approvals. He also has an interest both in developing new biomarkers and targeted therapies in pancreatic cancer. Dr. Babiker is currently the Associate Director, Clinical Research Operations Mayo Clinic Cancer Center, FL.
Dr. Babiker earned his M.D. with High Honors from Univerzita Komenskeho, Slovakia, and completed a residency in Internal Medicine and a fellowship in Geriatrics and Gerontology at Weill Cornell Medical College, New York Presbyterian Hospital. Dr. Babiker was an instructor in medicine at the Mayo Clinic College of Medicine in Phoenix. He also completed a Hematology and Medical Oncology fellowship at the University of Arizona where he also served as Chief Fellow. Dr. Babiker is a member of the American Society of Clinical Oncology, American Association for Cancer Research, and the American College of Physicians. He has authored several abstracts and peer review manuscripts and has a passion for teaching and mentoring students and trainees.
Mintallah Haider, MD
Associate Member,
Department of Gastrointestinal Oncology
Moffitt Cancer Center
Associate Professor of Oncologic Sciences
University of South Florida
Tampa, FL
Mohamedtaki Tejani, MD
Medical Director, GI Oncology Program
Advent Health Cancer Institute
Orlando, FL
Mohamedtaki A. Tejani received his Bachelor of Arts degree, magna cum laude from Amherst College. He later earned his medical degree from Dartmouth Medical School. Dr. Tejani went on to complete his residency at Yale-New Haven Hospital in New Haven, CT, achieving the rank of Chief Resident. Following this, he completed his fellowship training in hematology/oncology at Fox Chase Cancer Center/Temple University in Philadelphia.
An award-winning physician, Dr. Tejani has authored numerous oncology-related publications. His research experience and areas of interest include gastrointestinal cancers, biomarkers and therapeutics, patient-provider communication and the culture of medicine. Dr. Tejani firmly believes that patient care is a privilege. Listening and responding to a patient's unique story is critical in helping that family on their cancer journey. Originally from Tanzania (East Africa), he is fluent in Swahili, Hindi, Urdu and Gujarati.
Michelle Gulbrandson, MSN, APRN, FNP-C, AGACNP-B
APP Manager Cancer Services
Fred & Pamela Buffett Cancer Center
Omaha, NE
Jason Starr, DO
Oncologist
Department of Internal Medicine
Mayo Clinic
Jacksonville, FL
Available Credit
- 8.50 ABIM Medical KnowledgeHorizon CME, Inc. designates this activity for a maximum of 8.50 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 8.50 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
- 8.50 ACPE PharmacyThe Washington State Pharmacy Association is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This conference is approved for up to 8.50 credit by the Washington State Pharmacy Association.
This activity is approved for up to 8.50 credit by the Washington State Pharmacy Association. Activity Type: Live| Start/End date: Fri, 02/20/2026 - 11:00am-Sat, 02/21/2026 - 1:50pm The Washington State Pharmacy Association (WSPA) is accredited by the Accreditation Council for Pharmacy Education as a Provider of continuing pharmacy education. NOTE FOR PHARMACISTS: It is the responsibility of the pharmacist or pharmacy technician to provide the correct information [NABP eProfile ID and DOB (in MMDD format)] within the evaluation, in order to receive credit for participating in this CPE activity. Following the activity’s end date, there is a maximum of 60 days allowed to upload the CPE information to the CPE Monitor. WSPA will upload the CPE information to the CPE monitor 60 days after the activity - please check your CPE Monitor at this time to ensure the CPE is uploaded in your profile. If you encounter any CPE problems, please contact WSPA at 425- 228-7171 - 8.50 AMA PRA Category 1 Credit™
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME). Horizon CME is accredited by the ACCME to provide continuing medical education for physicians.
Horizon CME designates this Live activity for a maximum of 8.50 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- 8.50 ANCCThis activity has been planned and implemented in accordance with the accreditation requirements and policies of the American Nurses Credentialing Center’s Commission on Accreditation through the joint providership of the Nurse Practitioner Healthcare Foundation and Horizon CME. The Nurse Practitioner Healthcare Foundation is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation. NPHF is awarding the contact hours and is responsible for adherence to the ANCC criteria. Upon completion, NPs and RNs will be awarded up to 8.50 credit.
- 2.00 PharmacologyThis activity has been planned and implemented in accordance with the accreditation requirements and policies of the American Nurses Credentialing Center’s Commission on Accreditation through the joint providership of the Nurse Practitioner Healthcare Foundation and Horizon CME. The Nurse Practitioner Healthcare Foundation is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation. NPHF is awarding the contact hours and is responsible for adherence to the ANCC criteria. Upon completion, NPs and RNs will be awarded up to 2.00 credit.